Ultrasound imaging to detect and track peripheral arterial disease
Tests a painless ultrasound method for finding and following peripheral arterial disease.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 14 Mar 2025
- Expected to end
- 30 Aug 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Ultrasound Imaging
- Record updated
- 5 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with leg pain when walking (claudication) who may have peripheral arterial disease (PAD), and healthy volunteers. It tests a new ultrasound scan of blood flow.
- Age
- Patients: 18 years and up. Healthy volunteers: 18-75 years. The record lists 18 Years to 75 Years overall.
- Sex
- Men and women can join.
- Disease stage
- Patients must have leg pain when walking (claudication), be suspected of having PAD and be scheduled for blood vessel tests. Healthy volunteers must have a normal ankle-brachial index (ABI) and a normal BMI, not more than 30.
- Earlier treatment
- Patients who are having surgery or a stent cannot join.
Main reasons for not taking part
- Gangrene or an ulcer (open sore) on the leg
- Having surgery or a stent
- Any health condition that does not allow proper ultrasound scanning
- People considered in "vulnerable" populations
- Healthy volunteers: any history of smoking, diabetes, high blood pressure or heart and blood vessel disease
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Patient volunteers:
- Male and Female, ages 18 years old and up
- Symptom of claudication and suspected for PAD
- Scheduled for vascular testing; Healthy volunteers:
- Male and female, ages 18-75 years old and up
- Normal BMI
- No history of smoking, cardiovascular disease, or diabetes
Who cannot take part
- Patients having surgery or stent
- Patients with ulcer on their leg
- Any health condition that does not allow proper use of ultrasound scanning
- No history of smoking
- No history of (diabetes, hypertension, cardiovascular diseases)
- Patient volunteers:
- Patients with gangrene
- People considered in "vulnerable" populations; Healthy volunteers:
- Include volunteers with BMI not more than 30
- People considered in "vulnerable" populations
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- Mayo Clinic in RochesterRochester, United StatesContact: Azra Alizad, MDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to develop a new noninvasive tool for early diagnosis of Peripheral Arterial Disease (PAD) and use the proposed method for monitoring the disease progression and the response to interventional treatment in PAD patients.
The 2 groups in the trial
- Study GroupTreatment being tested
Symptomatic patients with claudication, at risk for peripheral arterial disease (PAD)
Treatment: Ultrasound Imaging
- Healthy VolunteersTreatment being tested
Healthy volunteers with normal ankle-brachial index (ABI)
Treatment: Ultrasound Imaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Ultrasound Perfusion Estimation for Assessment of PAD
- Plain-language title
- Ultrasound imaging to detect and track peripheral arterial diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06952543, who can take part
- Record updated
- 5 May 2026